½ÃÀ庸°í¼­
»óǰÄÚµå
1764952

ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå : ¿¹Ãø - Áö¿ªº° ºÐ¼® - À¯Çü, Àç·á, ¿ëµµº°(-2031³â)

North America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 107 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀº 2023³â¿¡ 2¾ï 4,786¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 3¾ï 6,053¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023-2031³âÀÇ CAGRÀº 4.8%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

´ëµ¿¸Æ·ù °á¼ÕÀÇ À¯º´·ü »ó½ÂÀÌ ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀ» ÃËÁø

´ëµ¿¸Æ·ù´Â ½ÅüÀÇ ÁÖ¿ä µ¿¸Æ ¶Ç´Â ´ëµ¿¸ÆÀÇ º®ÀÌ ºÎÇ®¾î ¿À¸£´Â °ÍÀÔ´Ï´Ù. µ¿¸Æ·ù ÆÄ¿­ÀÇ ºñÀ²ÀÌ ³ô¾Ò½À´Ï´Ù. ÇöÀç ´ëµ¿¸Æ·ùÀÇ °³¹ßÀ» ¿¹¹æÇÏ´Â È¿°úÀûÀÎ ¾à¹°Àº ¾øÀ¸¸ç, À¯ÀÏÇÑ Ä¡·á ¿É¼ÇÀº ¼ö¼ú ¶Ç´Â Ç÷°ü ³» ¼öº¹¼úÀÔ´Ï´Ù. ¸»ÃÊ Ç÷°ü »öÀü¿ë ÄÚÀÏ, ½Ã¾Æ³ë¾ÆÅ©¸±·¹ÀÌÆ® ¶Ç´Â ÇǺ기 Á¢ÂøÁ¦, °ÖÆû, Onyx µîÀÌ ´ëµ¿¸Æ·ù·ÎºÎÅÍÀÇ ¿£µå¸®Å©ÀÇ Ä¡·á¿¡ ÀÚÁÖ »ç¿ëµÇ´Â »öÀü±â±¸ÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀº ÄÚÀÏÀº ÀϺΠ¼±Ãµ¼º ½ÉÀå Áúȯ, ´©°ø, µ¿¸Æ·ù, °ü»ó µ¿¸Æ ¿ìȸ¼ú ÈÄ µ¿¸Æ ÃøÁö ½ºÅ×ÀÏ ÁõÈıºÀÇ Ä¡·á¸¦ À§ÇØ ¼±ÅÃÀûÀÎ Àå¸é¿¡¼­µµ »ç¿ëµÉ ¼ö ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå °³¿ä

ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ ½ÃÀå ½Ã³ª¸®¿À¿¡ µû¶ó ºÐ¼®µÇ°í ÀÖ½À´Ï´Ù. »ç·Ê´Â 50¼¼ ÀÌÈÄ¿¡ º¸°íµÇ¾î, »ç·ÊÀÇ ºÐÆ÷´Â ¼ºº° ¸ðµÎ µ¿µîÇÕ´Ï´Ù. ±× °á°ú, Æò±Õ ¼ö¸íÀÇ ¼ºÀå°ú ÇÔ²² ½Å±Ô »ç·Ê ¼ö¿Í »ç¸Á·üÀº ²ÙÁØÈ÷ »ó½ÂÇϰí ÀÖ½À´Ï´Ù. Ãß°¡ÀûÀ̰í ħ½ÀÀûÀÎ Ä¡·á ¿É¼ÇÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏÀº Ç÷°üÀ» ¸·°í ÃâÇ÷À» ¿¹¹æÇϰųª Ç¥Àû ºÎÀ§ÀÇ Ç÷·ù¸¦ ÁÙÀÌ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. »ç¶÷µéÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ ÁÖ·ÂÇÏ´Â µ¿¾È ÀÌ·¯ÇÑ ÄÚÀÏ¿¡ ´ëÇÑ ¼ö¿ä´Â ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¸ß½ÃÄÚ¿¡¼­´Â ¾Ï ÀÌȯÀ²ÀÌ »ó½ÂÇϰí ÀÖÀ¸¸ç, ´ëÀå¾ÏÀº Áø´Ü ºóµµ°¡ ³ôÀº ¾ÏÀÇ 3À§¿¡ ·©Å©µÇ°í ÀÖ½À´Ï´Ù. ¸ß½ÃÄÚÀÇ ´ëÀå¾Ï ½ÃÀåÀº ¾Ï Á¶±â ¹ß°ß Ä·ÆäÀÎÀ» °­È­Çϱâ À§ÇØ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºñÀ²Àº 100,000¸í´ç 4.7¸íÀÔ´Ï´Ù. ¸¶ÀÌÅ©·ÎÄÚÀÏ »öÀü¼úÀº »óºÎ ¼ÒÈ­°ü ÃâÇ÷¿¡ ´ëÇØ È®¸³µÈ Ä¡·á¹ýÀ̸ç, ÃâÇ÷ ºÎÀ§¿¡ °¡±î¿î Àå¼Ò¿¡¼­ ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ö¼úÀº ±Þ¼º ÇϺΠ¼ÒÈ­°ü ÃâÇ÷À» °ü¸®ÇÏ´Â ¾ÈÀüÇϰí È¿°úÀûÀÎ ¹æ¹ýÀÔ´Ï´Ù. Canadian Journal of Surgery(CJS)°¡ 2021³â¿¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é, °æµ¿¸Æ »öÀü¼úÀº ºñÀå ÀÌ¿ÜÀÇ ¿Ü»óÀÇ Ä¡·á¿¡ ¼º°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÀýÂ÷´Â ¼º°ø·üÀÌ ³ô°í, ÇÕº´ÁõÀÇ ¹ß»ý·üµµ ³·½À´Ï´Ù. ¶ÇÇÑ, ij³ª´Ù º¸°ÇºÎ´Â µÎ°³³» µ¿¸Æ·ùÀÇ Ä¡·á¿¡ ¼ö¸¹Àº ÄÚÀϰú ÄÚÀÏ Àü´Þ ½Ã½ºÅÛÀ» ½ÂÀÎÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀÇ ¼öÀͰú 2031³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)

ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå ¼¼ºÐÈ­

ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀº À¯Çü, Àç·á, ¿ëµµ ¹× ±¹°¡·Î ºÐ·ùµË´Ï´Ù.

À¯Çüº°·Î´Â ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀº µðÅ×ÀÌÃĺí ÄÚÀϰú Ǫ¼Åºí ÄÚÀÏ·Î À̺ÐÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àç·áº°·Î, ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀº ¹é±Ý, ¹é±Ý& ÇÏÀ̵å·Î°Ö, ¹é±Ý ÅÖ½ºÅÙ ÇÕ±ÝÀ¸·Î ºÐ·ùµË´Ï´Ù.

¿ëµµº°·Î´Â ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀº ÃâÇ÷ ¹× ¿Ü»ó, ±âÇü, Á¾¾ç, ³»Àå µ¿¸Æ·ù, ¿£µå¸®Å© IIÇü, Á¤¸Æ·ù·Î ±¸ºÐµË´Ï´Ù. ÃâÇ÷&¿Ü»ó ºÎ¹®ÀÌ 2023³â¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î´Â ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù.

Medtronic Plc, Penumbra, Inc., Balt, Boston Scientific Corp, Cook Medical Holdings LLC, Wallaby Medical, Spartan Micro Inc., Terumo Corp. µîÀÌ ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®
  • ½ÃÀåÀÇ ¸Å·Â

Á¦3Àå Á¶»ç ¹æ¹ý

  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
    • °¡¼³ÀÇ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀκм®
    • ÆÄ¿îµ¥ÀÌ¼Ç ¼öÄ¡ÀÇ °³¹ß
    • µ¥ÀÌÅÍÀÇ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦4Àå ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´ëµ¿¸Æ·ùÀÇ À¯º´·ü »ó½Â
    • ¾Ï ¹ß»ý·ü Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • »öÀü¼ú ½Ç½Ã Áß ¶Ç´Â ½Ç½Ã ÈÄ¿¡ ¹ß»ýÇÏ´Â ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • »öÀü¿ë ÄÚÀÏÀÇ ÀÀ¿ë ¹üÀ§ÀÇ È®´ë
  • ÇâÈÄÀÇ µ¿Çâ
    • ÃæÁø ¹ÐµµÀÇ Á߿伺 Áõ°¡
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦5Àå ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå : ºÏ¹ÌÀÇ ºÐ¼®

  • ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå °³¿ä
  • ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå ¼öÀÍ(2021-2031³â)
  • ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå ¿¹Ãø ºÐ¼®
  • ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå ±â¾÷ÀÇ Æ÷Áö¼Å´×

Á¦6Àå ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå ºÐ¼® - Á¦Ç° À¯Çüº°

  • ¼Ò°³
  • µðÅ×ÀÌÃĺí ÄÚÀÏ
  • Ǫ¼Åºí ÄÚÀÏ

Á¦7Àå ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå ºÐ¼® - Àç·áº°

  • ¼Ò°³
  • ¹é±Ý
  • Ç÷¡Æ¼³Ñ & ÇÏÀ̵å·Î°Ö
  • ¹é±Ý ÅÖ½ºÅÙ ÇÕ±Ý

Á¦8Àå ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå ºÐ¼® - ¿ëµµº°

  • ¼Ò°³
  • ÃâÇ÷¡¤¿Ü»ó
  • ±âÇü
  • Á¾¾ç
  • ³»À嵿¸Æ·ù
  • ¿£µå ¸®Å© IIÇü
  • Á¤¸Æ·ù

Á¦9Àå ºÏ¹ÌÀÇ ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå - ±¹°¡º° ºÐ¼®

  • ºÏ¹ÌÀÇ °³¿ä
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ

Á¦10Àå ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀå - »ê¾÷ Á¤¼¼

  • ¼Ò°³
  • ¸»ÃÊ»öÀü¼ú¿ë ÄÚÀÏ ½ÃÀåÀÇ ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Medtronic Plc
  • Penumbra, Inc.
  • Balt
  • Boston Scientific Corp
  • Cook Medical Holdings LLC
  • Wallaby Medical
  • Spartan Micro Inc.
  • Terumo Corp

Á¦12Àå ºÎ·Ï

SHW 25.07.14

The North America peripheral embolization coils market was valued at US$ 247.86 million in 2023 and is expected to reach US$ 360.53 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.

Rise in Prevalence of Aortic Aneurysm Loss Fuels North America Peripheral Embolization Coils Market

An aortic aneurysm is a bulging wall of the body's major artery or aorta. According to the American Heart Association's 2023 data, aortic aneurysms were the cause of 150,000 fatalities reported across the world in 2020, indicating a 26% rise from 2010. Smokers and women had greater rates of aneurysmal rupture. Currently, there are no effective medications to prevent the development of aortic aneurysms; the only treatment options are surgical or endovascular repair. Embolization agents are frequently used as substitutes for open surgeries, which are riskier and followed by longer recovery periods. Peripheral vascular embolization coils, cyanoacrylate or fibrin glue, gel foam, and Onyx are among the embolic devices that are commonly used to treat endoleaks from aortic aneurysms. Coiling is a suitable therapy option for peripheral aneurysms since it is less invasive than open surgical repair. Coils can also be used in elective settings to treat some congenital cardiac diseases, fistulas, aneurysms, and arterial side branch steal syndrome after coronary artery bypass grafting. Therefore, an upsurge in the prevalence of aortic aneurysms drives the growth of the peripheral embolization coils market.

North America Peripheral Embolization Coils Market Overview

The peripheral embolization coils market in North America has been analyzed based on the market scenarios in United States, Canada and Mexico. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. Colorectal cancer is the fourth most prevalent cancer in Mexico, with most cases reported after the age of 50, with a comparable distribution of cases in both genders. As a result, the number of new cases and rate of mortality have steadily climbed alongside the rising life expectancy. The peripheral embolization coil market in the United States is experiencing growth due to the increasing prevalence of vascular diseases, such as peripheral artery disease (PAD) and aneurysms, requiring minimally invasive treatment options. Peripheral embolization coils are essential for including blood vessels to prevent hemorrhage or reduce blood flow in targeted areas. As healthcare providers focus on improving patient outcomes with less invasive procedures, the demand for these coils is rising. Technological advancements, such as the development of more efficient and biocompatible coils, along with growing awareness of endovascular treatments, are further driving market expansion in the United States.

Cancer incidences are rising in Mexico, and colorectal cancer is ranked as the third most frequently diagnosed cancer. According to IMSS, every year approximately 15,000 new cases are registered with colon cancer in the country. The market for colorectal cancer in Mexico is expected to grow to increase the campaign for early detection of cancers. According to GLOBOCAN, in Mexico, the incidence rate of gastric cancer was 6.2% in 2020, with a mortality rate of 4.7 per 100,000 persons. Microcoil embolization is a well-established treatment for upper gastrointestinal bleeding that can be performed closer to the bleeding site. The procedure performed using a superselective catheter is a safe and effective way of managing acute lower gastrointestinal bleeding. According to Statista, trauma was the reason for ~600 per 100,000 hospitalizations in Canada in 2021. According to an article published by the Canadian Journal of Surgery (CJS) in 2021, transarterial embolization procedures are successfully being used to treat non-splenic traumatic injuries; the most common embolization technique is coiling with gel foam. These procedures have high success rates with low rates of complications. Moreover, Health Canada has approved numerous coils and coil delivery systems for the treatment of intracranial aneurysms. Coil embolization is used with other adjunct endovascular devices, such as stents and balloons.

North America Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

North America Peripheral Embolization Coils Market Segmentation

The North America peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the North America peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the North America peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the North America peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the North America peripheral embolization coils market is segmented into the US, Canada, and Mexico. The US dominated the North America peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the North America peripheral embolization coils market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Peripheral Embolization Coils Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rise in Prevalence of Aortic Aneurysm
    • 4.1.2 Increase in Incidence of Cancer
  • 4.2 Market Restraints
    • 4.2.1 Complications Arising During or After Embolization
  • 4.3 Market Opportunities
    • 4.3.1 Expanding Range of Applications of Embolization Coils
  • 4.4 Future Trends
    • 4.4.1 Growing Importance of Packing Density
  • 4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - North America Analysis

  • 5.1 North America Peripheral Embolization Coils Market Overview
  • 5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
  • 5.3 Peripheral Embolization Coils Market Forecast Analysis
  • 5.4 Peripheral Embolization Coils Market: Company Positioning

6. North America Peripheral Embolization Coils Market Analysis - by Product Type

  • 6.1 Overview
  • 6.2 Detachable Coil
    • 6.2.1 Overview
    • 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Pushable Coil
    • 6.3.1 Overview
    • 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Peripheral Embolization Coils Market Analysis - by Material

  • 7.1 Overview
  • 7.2 Platinum
    • 7.2.1 Overview
    • 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Platinum & Hydrogel
    • 7.3.1 Overview
    • 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Platinum Tungsten Alloy
    • 7.4.1 Overview
    • 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Peripheral Embolization Coils Market Analysis - by Application

  • 8.1 Overview
  • 8.2 Bleedings & Trauma
    • 8.2.1 Overview
    • 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Malformations
    • 8.3.1 Overview
    • 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Tumors
    • 8.4.1 Overview
    • 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Visceral Aneurysms
    • 8.5.1 Overview
    • 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Endoleak Type II
    • 8.6.1 Overview
    • 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Varicose Veins
    • 8.7.1 Overview
    • 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Peripheral Embolization Coils Market - Country Analysis

  • 9.1 North America Overview
    • 9.1.1 North America: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 9.1.1.1 United States: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.1 United States: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.1.2 United States: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.1.3 United States: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.2 Canada: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.1 Canada: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.2.2 Canada: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.2.3 Canada: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.3 Mexico: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.1 Mexico: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.3.2 Mexico: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.3.3 Mexico: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Peripheral Embolization Coils Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Penumbra, Inc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Balt
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Boston Scientific Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Cook Medical Holdings LLC
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Wallaby Medical
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Spartan Micro Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Terumo Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦